Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development
Ingenix's Biological Reasoning Engine fuses biological data through Modality Fusion, a new architecture for AI in drug development. In a recent oncology engagement, the Biological Reasoning Engine accomplished in minutes what had taken the partner biotech several years and millions of...
Ingenix's Biological Reasoning Engine fuses biological data through Modality Fusion, a new architecture for AI in drug development. In a recent oncology engagement, the Biological Reasoning Engine accomplished in minutes what had taken the partner biotech several years and millions of...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.